Adam Taich 10x Genomics, Inc. (TXG) insider trading activity

TXG Quotes by TradingView

Adam Taich is Chief Financial Officer of 10x Genomics, Inc.. Currently has a direct ownership of 331,588 shares of TXG, which is worth approximately $3.89 Million. The most recent transaction as insider was on May 22, 2025, when has been sold 4,044 shares (Class A Common Stock) at a price of $8.3 per share, resulting in proceeds of $33,565. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 332K
1.2% 3M change
n/a 12M change
Total Value Held $3.89 Million

Adam Taich Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2025
SELL
Open market or private sale
$33,565 $8.3 p/Share
4,044 Reduced 1.2%
331,588 Class A Common Stock
Mar 17 2025
BUY
Grant, award, or other acquisition
-
133,928 Added 28.52%
335,632 Class A Common Stock
Oct 23 2024
BUY
Grant, award, or other acquisition
-
201,704 Added 50.0%
201,704 Class A Common Stock

Also insider at

SLGC
SomaLogic, Inc. Healthcare
Interim CEO
AT

Adam Taich

Chief Financial Officer
Boulder, CO

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TXG